Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Dianthus Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 76
- +37 vs. Q4 2023
- Shares held
- 26.1M
- +15.8M (+153.4%) vs. Q4 2023
- Total value
- $782.3M
- +$675.7M (+634.5%) vs. Q4 2023
- New holders
- 39
- 24 more added
- Sold out
- 2
- 8 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 4,161,045 | $124.8M | 0.01% | +1,942,833+87.6% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,992,028 | $89.8M | 7.21% | +2,992,028 | New |
| Fairmount Funds Management LLC | 2,762,837 | $82.9M | 9.03% | +834,334+43.3% | Added |
| Avidity Partners Management LP | 2,717,554 | $81.5M | 2.90% | +1,500,000+123.2% | Added |
| Ra Capital Management, L.P. | 2,333,000 | $70.0M | 0.89% | +2,333,000 | New |
| VR Adviser, LLC | 2,094,373 | $62.8M | 2.99% | +1,166,667+125.8% | Added |
| Octagon Capital Advisors LP | 1,380,667 | $41.4M | 5.04% | +826,667+149.2% | Added |
| 5AM Venture Management, LLC | 1,242,029 | $37.3M | 8.34% | −230,235−15.6% | Reduced |
| RTW Investments, LP | 666,667 | $20.0M | 0.30% | +666,667 | New |
| Great Point Partners LLC | 625,000 | $18.8M | 2.92% | +625,000 | New |
| Vanguard Group Inc | 537,828 | $16.1M | 0.00% | +384,182+250.0% | Added |
| Vestal Point Capital, LP | 455,000 | $13.7M | 1.13% | +320,000+237.0% | Added |
| Janus Henderson Group PLC | 375,044 | $11.3M | 0.01% | +375,044 | New |
| Point72 Asset Management, L.P. | 352,100 | $10.6M | 0.03% | +352,100 | New |
| Adage Capital Partners GP, L.L.C. | 298,000 | $8.94M | 0.02% | +298,000 | New |
| Millennium Management LLC | 277,213 | $8.32M | 0.01% | +243,249+716.2% | Added |
| Tang Capital Management LLC | 264,692 | $7.94M | 0.83% | −239,550−47.5% | Reduced |
| Ally Bridge Group (NY) LLC | 216,968 | $6.51M | 3.62% | +216,968 | New |
| Alphabet Inc. | 208,697 | $6.26M | 0.25% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 205,487 | $6.16M | 0.01% | +176,808+616.5% | Added |
| Walleye Capital LLC | 190,266 | $5.71M | 0.06% | +190,266 | New |
| Atlas Venture Life Science Advisors, LLC | 186,979 | $5.61M | 0.52% | −50,000−21.1% | Reduced |
| Goldman Sachs Group Inc | 170,217 | $5.11M | 0.00% | +170,217 | New |
| Marshall Wace, LLP | 112,930 | $3.39M | 0.01% | +112,930 | New |
| Renaissance Technologies LLC | 105,704 | $3.17M | 0.00% | +56,398+114.4% | Added |
| Soleus Capital Management, L.P. | 100,000 | $3.00M | 0.26% | +100,000 | New |
| Jane Street Group, LLC | 82,051 | $2.46M | 0.00% | +66,373+423.4% | Added |
| Hudson Bay Capital Management LP | 80,000 | $2.40M | 0.02% | +80,000 | New |
| Geode Capital Management, LLC | 74,400 | $2.23M | 0.00% | +29,221+64.7% | Added |
| Qube Research & Technologies Ltd | 67,846 | $2.04M | 0.00% | +67,044+8,359.6% | Added |
| BlackRock Inc. | 46,615 | $1.40M | 0.00% | +14,309+44.3% | Added |
| StemPoint Capital LP | 43,456 | $1.30M | 0.35% | +43,456 | New |
| Two Sigma Investments, LP | 37,971 | $1.14M | 0.00% | +37,971 | New |
| The PNC Financial Services Group, Inc. | 37,100 | $1.11M | 0.00% | +37,100 | New |
| Fred Alger Management, LLC | 36,367 | $1.09M | 0.01% | −4,474−11.0% | Reduced |
| HRT Financial LP | 34,174 | $1.02M | 0.01% | +34,174 | New |
| Laurion Capital Management LP | 25,536 | $766.1K | 0.02% | −731−2.8% | Reduced |
| Citadel Advisors LLC | 24,829 | $744.9K | 0.00% | +24,829 | New |
| Cubist Systematic Strategies, LLC | 24,125 | $723.8K | 0.01% | +24,125 | New |
| Citigroup Inc | 22,736 | $682.1K | 0.00% | +5,329+30.6% | Added |
| American Century Companies Inc | 21,959 | $658.8K | 0.00% | +21,959 | New |
| Dimensional Fund Advisors LP | 21,728 | $651.8K | 0.00% | +6,992+47.4% | Added |
| Morgan Stanley | 21,084 | $632.5K | 0.00% | +21,029+38,234.5% | Added |
| Hussman Strategic Advisors, Inc. | 21,000 | $630.0K | 0.15% | +21,000 | New |
| ArrowMark Colorado Holdings LLC | 20,788 | $623.6K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 20,398 | $611.9K | 0.00% | +20,398 | New |
| Northern Trust Corp | 18,491 | $554.7K | 0.00% | +3,190+20.8% | Added |
| ExodusPoint Capital Management, LP | 16,996 | $510.0K | 0.01% | +16,996 | New |
| JPMorgan Chase & Co | 16,018 | $480.5K | 0.00% | +15,977+38,968.3% | Added |
| Bank of America Corp | 15,495 | $464.9K | 0.00% | +11,366+275.3% | Added |
| Bessemer Group Inc | 14,829 | $445.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 14,505 | $435.1K | 0.00% | +14,125+3,717.1% | Added |
| Marathon Trading Investment Management LLC | 14,500 | $435.0K | 0.17% | +14,500 | New |
| Barclays PLC | 14,403 | $432.1K | 0.00% | +14,400+480,000.0% | Added |
| Jump Financial, LLC | 13,942 | $418.3K | 0.01% | +13,942 | New |
| Squarepoint Ops LLC | 13,642 | $409.3K | 0.00% | +13,642 | New |
| Balyasny Asset Management LLC | 13,371 | $401.1K | 0.00% | +13,371 | New |
| Virtu Financial LLC | 12,995 | $390.0K | 0.03% | +12,995 | New |
| Brevan Howard Capital Management LP | 12,253 | $367.6K | 0.03% | +12,253 | New |
| Y-Intercept (Hong Kong) Ltd | 12,090 | $362.7K | 0.03% | +12,090 | New |
| RBF Capital, LLC | 10,784 | $323.5K | 0.02% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 10,345 | $310.4K | 0.08% | +10,345 | New |
| Bank of New York Mellon Corp | 8,426 | $252.8K | 0.00% | +8,426 | New |
| Engineers Gate Manager LP | 7,786 | $233.6K | 0.01% | +7,786 | New |
| Jefferies Financial Group Inc. | 7,600 | $228.0K | 0.00% | −5,600−42.4% | Reduced |
| LMR Partners LLP | 7,478 | $224.3K | 0.01% | +7,478 | New |
| XTX Topco Ltd | 7,219 | $216.6K | 0.03% | +7,219 | New |
| Polymer Capital Management (HK) LTD | 6,686 | $200.6K | 0.05% | +6,686 | New |
| Acadian Asset Management LLC | 4,012 | $120.0K | 0.00% | −13,876−77.6% | Reduced |
| Tower Research Capital LLC (TRC) | 3,897 | $116.9K | 0.00% | +1,467+60.4% | Added |
| EntryPoint Capital, LLC | 363 | $10.9K | 0.01% | +363 | New |
| Wells Fargo & Company | 224 | $6.72K | 0.00% | +150+202.7% | Added |
| Fernwood Investment Management, LLC | 102 | $3.06K | 0.00% | +102 | New |
| Royal Bank of Canada | 81 | $2.00K | 0.00% | −254−75.8% | Reduced |
| Institutional & Family Asset Management, LLC | 3 | $90 | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 1,824 | $55 | 0.00% | +1,824 | New |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −328,433−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −481−100.0% | Sold out |